Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 892,458Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 26BIOXCEL

02 38HOSPIRA

03 4HQ SPCLT PHARMA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11998529

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11998529

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 12109196

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 12109196

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11998528

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-12

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11998528

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2043-01-12

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11890272

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11890272

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3935

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-17

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11786508

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3698

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-29

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXMEDETOMIDINE HYDROCHLORIDE

US Patent Number : 11786508

Drug Substance Claim :

Drug Product Claim :

Application Number : 215390

Patent Use Code : U-3698

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-29

blank